Markets › United States › NYSE › BAX

Baxter International Inc

NYSE:BAXHealthcareCBOE:SPESGSTOXX:EDD24BP

$24.99−1.15%At closeAt close · Tue 20 Oct · ≈ AED 91.78 · Market cap $12.92B · Next earnings Thu 29 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	39.3%	38.9%	35.3%	40.1%	37.5%	30.1%	—	—
Operating margin	13.8%	11.1%	−28.3%	6.8%	0.1%	−2.7%	−2.7%	+0.0 pts
Net margin	9.4%	10.6%	−24.2%	25.6%	−6.1%	−8.5%	−8.5%	+0.0 pts
EBITDA margin	19.4%	18.0%	−17.5%	16.7%	10.5%	6.8%	—	—
Return on equity	12.7%	14.1%	−41.7%	31.6%	−9.3%	−15.6%	−15.7%	−0.1 pts
Return on assets	5.5%	3.8%	−8.6%	9.4%	−2.5%	−4.8%	−4.8%	+0.0 pts
Return on capital employed	9.7%	4.6%	−12.1%	3.2%	0.1%	−1.8%	—	—
Debt / equity	0.8×	2.0×	2.9×	1.7×	1.9×	1.6×	1.6×	+0.4%
Debt / assets	34.0%	54.6%	60.8%	49.9%	52.2%	49.9%	—	—
Interest coverage	10.6×	6.5×	−6.9×	1.4×	0.0×	−1.1×	—	—
Current ratio	2.5×	2.1×	1.7×	1.5×	1.4×	2.3×	2.3×	+0.0%
Quick ratio	1.9×	1.5×	1.1×	1.2×	1.0×	1.6×	—	—
Cash ratio	1.1×	0.7×	0.4×	0.5×	0.3×	0.7×	0.7×	+0.0%
Asset turnover	0.6×	0.4×	0.4×	0.4×	0.4×	0.6×	—	—
Inventory turnover	3.7×	3.0×	2.4×	3.2×	3.3×	3.5×	—	—
Receivables turnover	5.6×	4.5×	3.8×	5.8×	6.1×	5.8×	—	—
Dividend payout	42.9%	41.3%	−23.6%	22.1%	−90.9%	−36.4%	—	—